Duract (bromfenac) was on the market less than a year

Duract (bromfenac) was on the market less than a year.

This NSAID worked well for acute pain, but got pulled becauseof reports of severe hepatic failure in patients who used Duract formore than 10 days or had pre-existing hepatic disease.

In fact, its labeling had a black-box warning not to take itfor more than 10 days because of the risk of hepatic toxicity.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote